PeRiOperative Medicine Platform Trial

PHASE4RECRUITING

Our specific aims are to investigate whether conservative (≤30%), intermediate (50%), or liberal (80%) inspired oxygen during and immediately after surgery: Aim 1: Reduces surgical site infections (SSIs or "wound infections") and other healthcare-associated infections (pneumonia and sepsis). Aim 2: Reduces a pooled composite of serious postoperative complications, leading to a faster and more complete recovery after surgery, and thus increases "days alive and at home up to 30 days after surgery" (DAH30). Primary hypothesis: Liberal (80%) oxygen concentration delivered with anesthesia in patients undergoing major surgery reduces the incidence of SSIs after surgery compared to conservative (≤30%) or intermediate (50%) oxygen concentration.

Secondary hypothesis: Hyperoxia (50-80%) delivered with anesthesia in patients undergoing major surgery increases the incidence of pulmonary and other complications after surgery compared to conservative (≤30%) oxygen concentration, resulting in fewer Days At Home (DAH). PROMPT enrolls patients undergoing elective or semi-elective surgery.

Study details:

www. promptssi. org.

au.

Eligibility criteria

Researchers look for people who fit a certain description, called eligibility criteria. See if you qualify.

Inclusion criteria

  1. Adult patient (≥18 years of age at time of admission)
  2. Scheduled to undergo a surgical procedure involving a skin incision, with an expected duration of at least 2 hours, and a planned overnight hospital stay of at least 1 night (including, but not limited to, cardiac surgery, orthopedic surgery, obstetric, or gynecological surgery).

Exclusion criteria

  1. ASA physical status 5 (moribund, not expected to survive with or without an operation)
  2. Inability to provide informed consent
  3. Previous participation in PROMPT within the prior 30 days.
  4. ASA physical status 1 or 2
  5. Undergoing cardiac surgery
  6. Undergoing thoracic surgery if one-lung ventilation is required
  7. Currently suspected or proven infection
  8. Advanced lung disease requiring home oxygen therapy
  9. Previous bleomycin therapy
  10. Known or suspected pregnancy

Eligibility

Age eligible for study : NA

Healthy volunteers accepted : No

Gender eligible for study: ALL

Things to know

Study dates

Study start:

Primary completion:

Study completion finish:

study type

Study type

TREATMENT

phase

Phase

    PHASE4

trial

Study ID

NCT07186634

Intervention or treatment

DRUG: Liberal inspired oxygen

DRUG: Conservative inspired oxygen

DRUG: Intermediate inspired oxygen

Conditions

  • Surgical Site Infection After Major Surgery
  • Anaesthesia
  • Major Complications
  • Quality of Recovery (QoR-15)
  • Quality of Life
  • Condition: Surgical Site Infection After Major Surgery, Anaesthesia and more

  • DRUG: Liberal inspired oxygen and other drugs

  • Melbourne, Victoria, Australia

  • Sponsor: Monash University

You may be eligible to participate in this trial based on your search. Check eligibility by answering some questions.

Are you running this trial?

If you're a clinic or sponsor, you can claim this study

Research sites nearby

Closest Location:

The Alfred

Select from list below to view details:

  • The Alfred

    Melbourne, Victoria, Australia

Loading map...

Who is running the clinical trial?

MU

Monash University

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Participant Group/ArmIntervention/Treatment
ACTIVE_COMPARATOR: Liberal inspired oxygen
  • FiO2 0.8; i.e. 80%
Drug: Liberal inspired oxygen
    ACTIVE_COMPARATOR: Conservative inspired oxygen
    • FiO2 ≤0.3 \[30%\]
    Drug: Conservative inspired oxygen
      ACTIVE_COMPARATOR: Intermediate inspired oxygen
      • FiO2 0.5 \[50%\]
      Drug: Intermediate inspired oxygen

        What is the study measuring?

        Primary Outcome

        MeasureDescriptionTime Frame
        Surgical Site InfectionA post operative infection that develops at the site of an operation, caused by bacteria entering the body through the surgical incision30 days

        Secondary Outcome

        MeasureDescriptionTime Frame
        Health Care Associated Infectionspneumonia, blood stream infection and urinary tract infection30 days
        Quality of recoveryQuality of the individual's recovery post surgery - PROM. The scores of all 15 questions, with each item rated on a scale that results in a total score ranging from 0 (very poor recovery) to 150 (excellent recovery)3 and 30 days after surgery
        major postoperative complicationsDescription: A composite (and individually): Cardiovascular events (myocardial infarction, arterial or venous thrombosis, stroke, acute pulmonary edema, cardiogenic shock, new cardiac arrhythmia requiring treatment) Sepsis or septic shock (defined according to the Sepsis-3 definition)25 Respiratory complications - (i) pneumonia using US Centers for Disease Control criteria, (ii) Acute Respiratory Distress Syndrome using Berlin consensus definition, or (iii) the need for tracheal re-intubation and mechanical ventilation after extubation, and within 30 days after surgery OR mechanical ventilation for more than 24 h after surgery26 Unplanned intensive care unit (ICU) admission or readmission, defined as not anticipated preoperatively Acute kidney injury (based on the serum creatinine item of the Kidney Disease Improving Global Outcome criteria) Need for surgical re-intervention within 30 days after surgery Death within 30 days after surgery. Time Frame: 30 days30 days
        MortalityAll cause30 days
        EQ-5D-5LQuality of life (EQ-5D-5L) at 30 days after index surgery. The resulting EQ-5D index score is a numerical value, with 1 representing full health, and scores less than 1 representing poorer health states, including negative values that indicate health states worse than death.30 days
        DAH 30Days alive and at home at 30 days (DAH30) after index surgery (reflecting the patient's primary aim of a healthy recovery, reduced hospital costs and the impact/severity of serious complications, and avoiding re-admission (often due to SSI).30 days
        Are you running this trial?If you're a clinic or sponsor, you can claim this study.

        References

        Clinical Trials Gov: PeRiOperative Medicine Platform Trial

        Other trials to consider

        Loading suggested trials...

        Top searched conditions